Olave's Medical Clearance Opens Extension Window for Saints

Chris Olave received full medical clearance this week after a blood clot was detected in his lung during the 2025 season, per ESPN. The Saints' front office now has a clear path to negotiate an extension with the receiver, who is in the final year of his rookie deal. Mickey Loomis confirmed Olave is "full go," signaling both confidence in his health and urgency around locking him into a multi-year agreement before the franchise tag becomes the only mechanism to retain him.

Olave's 2025 season ended prematurely due to the clot discovery in January—roughly six months ago—but the resolution came faster than many medical protocols for similar conditions. The receiver reported no structural lung damage and has cleared all cardiology evaluations. For a player who had just completed his third NFL season averaging 94 receiving yards per game and 1.1 touchdowns per contest over his career, the absence of lingering complications is the outcome the Saints needed to move forward with confidence.

From a roster construction standpoint, Olave's health status directly impacts the Saints' cap flexibility and receiving corps depth. If New Orleans extends him now—likely to a deal worth $20+ million annually given recent WR market comparables—they reset his cap hit and create salary cap relief. Olave's partial hold-in, reported this week, is negotiating leverage; it signals he expects a deal that reflects his production and durability. The Saints cannot afford to lose him on the open market or through a franchise tag in 2027, and Olave knows this.

For prop bettors, the medical clearance removes uncertainty from Olave's snap count availability for the 2026 season. A receiver in a contract year, fully healthy, and confident he's staying in New Orleans is a high-leverage situation. Look for elevated targets and red-zone touches once the season begins—the Saints will want to showcase Olave's market value and reward his patience during the recovery window. His receiving yardage total and anytime TD likelihood should price in stronger usage rates than last season, when the clot disrupted his final games.

The clearest edge is fading pessimism on his durability props. The market may initially discount Olave's season-long receiving totals due to the medical scare, but a receiver with his talent, in a contract-year situation, on a team desperate to extend him, will see elevated targets. That's not volatility—that's organizational intent reflected in snap distribution. If his over/under on season receiving yards opened conservatively due to injury caution, that's the side to chase before Vegas tightens the number.